List view / Grid view



Smartfish’s medical drink trial a success for COPD patients suffering from cachexia

20 September 2016 | By Niamh Louise Marriott, Digital Content Producer

Cachexia is a condition of involuntary weight loss, undernourishment and a number of negative side-effects that can be seen in patients with Chronic obstructive pulmonary disease (COPD), as well as in cancer and in several severe inflammatory diseases, such as AIDS, congestive heart failure, tuberculosis and rheumatoid arthritis...